Почетна › Акутна миелоидна леукемија › Њујорк › Buffalo
Клинички испитувања за Акутна миелоидна леукемија во Buffalo, NY
19 студии за Акутна миелоидна леукемија бараат учесници на локации во и околу Buffalo (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Се регрутираФаза 2
- Roswell Park Cancer Institute, Buffalo
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Се регрутираФаза 2
- Roswell Park Cancer Institute, Buffalo
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Се регрутираФаза 2
- Roswell Park Cancer Institute, Buffalo
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Се регрутираФаза 3
- Roswell Park Comprehensive Cancer Center, Buffalo
Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Се регрутираФаза 1
- Roswell Park Cancer Institute, Buffalo
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Се регрутираФаза 2
- Roswell Park Cancer Institute, Buffalo
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Се регрутираФаза 2
- Roswell Park Cancer Institute, Buffalo
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Се регрутираФаза 2
- Roswell Park Cancer Institute, Buffalo
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Се регрутираФаза 3
- Roswell Park Cancer Institute, Buffalo
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
Се регрутираФаза 1/2
- Roswell Park Comprehensive Cancer Center, Buffalo
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Се регрутираФаза 3
- State University of New York at Buffalo, Buffalo
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Се регрутираФаза 1
- Roswell Park Comprehensive Cancer Center, Buffalo
Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents
Се регрутираФаза 2
- Roswell Park Cancer Institute, Buffalo
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Се регрутираНабљудувачка студија
- Roswell Park Cancer Institute, Buffalo
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Се регрутираФаза 2/3
- Roswell Park Comprehensive Cancer Center, Buffalo
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Се регрутираФаза 1/2
- Roswell Park Comprehensive Cancer Center, Buffalo
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Се регрутираФаза 1
- Roswell Park Comprehensive Cancer Center, Buffalo
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Се регрутираФаза 1
- Roswell Park Cancer Institute, Buffalo
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Се регрутираФаза 1
- Roswell Park Cancer Institute, Buffalo
Испитувања за Акутна миелоидна леукемија во други градови
- Houston, TX85 студии
- New York City, NY51 студија
- Boston, MA44 студии
- Seattle, WA41 студија
- Baldwin Park, CA40 студии
- Columbus, OH35 студии
- Philadelphia, PA34 студии
- Durham, NC33 студии
- Atlanta, GA31 студија
- Tampa, FL29 студии
- Chicago, IL26 студии
- Portland, OR25 студии
Други студии во Buffalo
- Рак на бели дробови со не-мали клетки19 студии
- Рак (сите типови)19 студии
- Рак на бели дробови16 студии
- Рак на дојка16 студии
- Карцином на јајниците13 студии
- Метастатски карцином11 студии
- Рак на простата11 студии
- Меланом10 студии
- Множен миелом10 студии
- Дебелина9 студии
- Беркитов лимфом8 студии
- Миелодиспластични синдроми8 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.